Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Boston Scientific has proven itself to be a fierce ... gave Boston solid footing to compete in the evolution toward pulsed field ablation to treat atrial fibrillation. We're more wary of the ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE ... for cardiac ablation procedures with the FARAPULSE™ Pulsed Field Ablation (PFA) System. These technologies are compatible ...

Boston Scientific has received U.S. FDA approval ... for cardiac ablation procedures with the FARAPULSE™ Pulsed Field Ablation (PFA) System. Today, physicians may utilize a separate mapping ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation ... Feast and Field ...